| Literature DB >> 26978871 |
Abstract
Graves disease associates thyroid and non-thyroid symptoms and signs with autoimmune pathogeny, including the ophthalmopathy. The treatment of Graves ophthalmopathy consists of medical immunosuppressive therapy, retrobulbar injections and general treatment. Recently, Somatostatin injections have proved their efficiency.Entities:
Mesh：
Substances：
Year: 2015 PMID： 26978871 PMCID： PMC5712926
Source DB: PubMed Journal: Rom J Ophthalmol ISSN： 2457-4325